INNOVATE Corp. (VATE) grants director Brian Goldstein 12,016 restricted shares

Rhea-AI Filing Summary

Goldstein Brian Steven reported acquisition or exercise transactions in this Form 4 filing.

INNOVATE Corp. director Brian Steven Goldstein received a grant of 12,016 shares of common stock as restricted stock under the company’s Second Amended and Restated 2014 Omnibus Equity Award Plan. These shares will vest on the earlier of the first anniversary of the grant date or the next regular annual stockholders’ meeting, subject to continued service, bringing his direct holdings to 60,999 shares.

Insider Trade Summary

Net Buyer: 12,016 shares

Net Buy 1 txn

Insider Goldstein Brian Steven

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	12,016	$0.00	$0.00

Holdings After Transaction: Common Stock — 60,999 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).

Key Figures

Restricted shares granted: 12,016 shares Grant price per share: $0.00 per share Shares held after grant: 60,999 shares +2 more

5 metrics

Restricted shares granted 12,016 shares Grant of restricted common stock to director Brian Steven Goldstein

Grant price per share $0.00 per share Reported transaction price for the restricted stock award

Shares held after grant 60,999 shares Total direct holdings of common stock following the award

Vesting trigger 1 First anniversary of grant date One of the alternative vesting conditions for the restricted shares

Vesting trigger 2 First regular annual meeting after grant Alternative vesting condition, subject to continued service

Key Terms

restricted stock, Omnibus Equity Award Plan, vesting date

3 terms

restricted stock financial

"Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Omnibus Equity Award Plan financial

"pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan"

vesting date financial

"subject to continued service with the Company through such vesting date"

FAQ

What transaction did INNOVATE Corp. (VATE) report for Brian Steven Goldstein?

INNOVATE Corp. reported that director Brian Steven Goldstein received a grant of 12,016 shares of restricted common stock. The award was made under the company’s 2014 Omnibus Equity Award Plan as amended.

How many INNOVATE Corp. (VATE) shares does Brian Steven Goldstein hold after this grant?

After the reported grant, Brian Steven Goldstein directly holds 60,999 shares of INNOVATE Corp. common stock. This total includes the newly granted 12,016 restricted shares subject to vesting conditions.

What are the vesting conditions for the 12,016 restricted shares at INNOVATE Corp. (VATE)?

The 12,016 restricted shares vest on the earlier of (i) the first anniversary of the grant date or (ii) the first regular annual stockholders’ meeting after grant, conditioned on continued service with the company through the vesting date.

Was the INNOVATE Corp. (VATE) restricted stock grant to Brian Steven Goldstein a market purchase?

No. The 12,016 shares were reported as a grant or award acquisition with a price per share of $0.00, indicating compensation-related equity rather than an open-market purchase.

Is the INNOVATE Corp. (VATE) restricted stock grant part of an equity plan?

Yes. The 12,016-share award was granted under the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, which governs the company’s equity-based compensation grants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 04:13 PM Accepted by SEC EDGAR 08/13/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldstein Brian Steven

(Last) (First) (Middle)

C/O INNOVATE CORP.

295 MADISON AVENUE, 12TH FL

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INNOVATE Corp. [ VATE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		A(1)		12,016	A	$0	60,999	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).

Remarks:

	/s/ Brian S. Goldstein	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)